{"id":629964,"date":"2026-09-28T11:02:18","date_gmt":"2026-09-28T11:02:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/629964\/"},"modified":"2026-09-28T11:02:18","modified_gmt":"2026-09-28T11:02:18","slug":"yakin-teams-up-with-hospital-umra-bags-two-biotech-records","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/629964\/","title":{"rendered":"Yakin teams up with Hospital UMRA, bags two biotech records"},"content":{"rendered":"<p>KUALA LUMPUR: Yakin Splendour Global Holdings Bhd (Yakin) has formalised a strategic collaboration with Hospital UMRA and received two national recognitions from the Malaysia Book of Records through its subsidiary, Merkel Clinic Velocity.<\/p>\n<p>The partnership with Hospital UMRA, a private multidisciplinary medical provider operating in Shah Alam since 2006, was sealed through a Memorandum of Understanding (MoU) signed by Yakin director Datuk Steven Lai and Hospital UMRA founder and medical director Datuk Dr Mohamed Rafi Mohammed Feizal.<\/p>\n<p>Located in Shah Alam\u2019s Section 13, Hospital UMRA serves a broad and predominantly Muslim patient community, guided by a vision to be a \u2018hospital of choice\u2019 through accessible, compassionate and consistently high\u2011quality care.<\/p>\n<p>The partnership combines Yakin\u2019s specialised expertise in umbilical cord-derived mesenchymal stem cell (UC-MSC) technology with Hospital UMRA\u2019s clinical infrastructure and patient-centred healthcare services.<\/p>\n<p>Both organisations aim to broaden access to advanced regenerative medicine while maintaining standards of quality, safety, clinical governance and patient care.<\/p>\n<p>\u201cBreakthrough science delivers its greatest value when it reaches the patient,\u201d said Lai.<\/p>\n<p>\u201cThrough this partnership with Hospital UMRA, we bring our UC\u2011MSC technology out of the laboratory and closer to patients \u2013 turning breakthrough science into real\u2011world healthcare solutions.<\/p>\n<p>\u201cHospital UMRA shares our belief that advanced medicine must be delivered responsibly, compassionately, and within reach. Together, we are building a vital bridge between biotechnology innovation and trusted clinical care,\u201d he added.<\/p>\n<p>The partnership is expected to support greater knowledge exchange, clinical cooperation and public awareness surrounding regenerative medicine, while strengthening Malaysia\u2019s capabilities in emerging areas of medical sciences.<\/p>\n<p>Welcoming the partnership, Dr Mohamed Rafi noted that Hospital UMRA has always been guided by quality, integrity and patient welfare.<\/p>\n<p>\u201cOur partnership with Yakin opens the door to advanced regenerative medicine, developed and delivered within a responsible, ethically sound clinical environment. It brings us closer to realising our vision: to be the healthcare provider of choice for the Muslim community and across the Klang Valley. Innovation and compassion must move forward together \u2013 always putting patient welfare first,\u201d he said.<\/p>\n<p>Merkel Clinic Velocity secures two Malaysia Book of Records awards<\/p>\n<p>Separately, Merkel Clinic Velocity secured two national honours from the Malaysia Book of Records, recognising it as Malaysia\u2019s first physoxic mesenchymal stem cell (MSC) provider and Malaysia\u2019s first P4 normoxic mesenchymal Stem Cell (MSC) developer.<\/p>\n<p>MSCs are widely used in regenerative medicine for their potential to support tissue repair, regulate immune and inflammatory responses, and form the foundation of future therapies. Cultivating these cells reliably through P4, a key laboratory growth stage, while maintaining full potency and consistency demands exceptional technical skill, rigorous standards and precision quality control.<\/p>\n<p><img decoding=\"async\" alt=\"(From left) Lai, Yakin Group of Companies founder and chief executive officer Dr Patrick Tan, Deputy Science, Technology, and Innovation Minister Datuk Dr Mohammad Yusof Apdal, Malaysia Book of Records chief operating officer Jwan Heah Yeow Hooi and Malaysia Book of Records official Aaron Bong Ken Jin during the presentation of the Malaysia Book of Records certificates recognising Merkel Clinic Velocity for its advancements in stem cell technology.\" src=\"https:\/\/apicms.thestar.com.my\/uploads\/images\/2026\/09\/28\/4133034.jpg\" onerror=\"this.src=\" https:=\"\" style=\"width: 620px; height: 413px;\"\/>(From left) Lai, Yakin Group of Companies founder and chief executive officer Dr Patrick Tan, Deputy Science, Technology, and Innovation Minister Datuk Dr Mohammad Yusof Apdal, Malaysia Book of Records chief operating officer Jwan Heah Yeow Hooi and Malaysia Book of Records official Aaron Bong Ken Jin during the presentation of the Malaysia Book of Records certificates recognising Merkel Clinic Velocity for its advancements in stem cell technology.<\/p>\n<p>Lai said these two records validate the company&#8217;s pursuit of excellence and its rigorous research and development mastery.<\/p>\n<p>\u201cThey reflect years of capital investment, scientific rigour, and a refusal to compromise on standards. This achievement belongs to every researcher, engineer, and partner who believed Malaysia could lead on the global stage. For Yakin, these honours are not the finish line \u2013 they are the foundation for scaling our technology, expanding our pipeline, and capturing regional market share.<\/p>\n<p>\u201cWe have proven that Malaysia can develop, manufacture, and deliver world\u2011class regenerative medicine. That is good for our industry, good for our economy, and good for the nation\u2019s global standing,\u201d said Lai.<\/p>\n<p>Building a regional regenerative medicine ecosystem<\/p>\n<p>The Hospital UMRA partnership and the two national records represent complementary pillars of Yakin\u2019s long\u2011term strategy to connect laboratory innovation with clinical delivery and build national capabilities that benefit all Malaysians.<\/p>\n<p>While the Hospital UMRA partnership strengthens the clinical outreach, the recognitions earned by Merkel Clinic Velocity demonstrate the group\u2019s commitment to developing specialised regenerative medicine capabilities within the nation.<\/p>\n<p>These milestones support Malaysia\u2019s broader ambition to become a competitive regional centre for biotechnology, medical research, healthcare innovation and regenerative medicine.<\/p>\n<p>Yakin remains focused on building an ecosystem where scientific innovation, responsible clinical practice and patient accessibility progress together, according to Lai.<\/p>\n<p>\u201cMalaysia has the talent, infrastructure and strategic location to become a regional leader in regenerative medicine,&#8221; Lai said, adding that realising that potential requires sustained investment, strategic collaboration, and a commitment to excellence.<\/p>\n<p>&#8220;Yakin is building the complete value chain, from laboratory R&amp;D to clinical delivery, creating high-value jobs, attracting investment, and positioning Malaysia as a destination for advanced biotech care.&#8221;<\/p>\n<p>He said Yakin\u2019s roadmap centres on fostering an ecosystem of collaboration, bringing together scientists, healthcare providers, regulators, and industry partners to drive standards, build trust, and unlock the sector\u2019s full economic and social potential.<\/p>\n<p>&#8220;With these milestones, Yakin has firmly established itself as Malaysia\u2019s flagship regenerative medicine enterprise, leading through innovation, scaling through partnership, and building a national industry with global reach,&#8221; he said.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"KUALA LUMPUR: Yakin Splendour Global Holdings Bhd (Yakin) has formalised a strategic collaboration with Hospital UMRA and received&hellip;\n","protected":false},"author":2,"featured_media":629965,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[76312,163,521,284815,85,46,284816,76313,284818,284817,284814],"class_list":["post-629964","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-digital-advertorial","tag-health","tag-healthcare","tag-hospital-umra","tag-il","tag-israel","tag-merkel-clinic-velocity","tag-starpicks","tag-uc-msc","tag-umbilical-cord-derived-mesenchymal-stem-cell","tag-yakin-splendour-global-holdings-bhd"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/629964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=629964"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/629964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/629965"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=629964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=629964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=629964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}